Citigroup Inc Leap Therapeutics, Inc. Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.92 - $1.75 $2,236 - $4,254	-2,431 Reduced 70.32%	1,026 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.96 - $1.91 $1,492 - $2,970	-1,555 Reduced 31.03%	3,457 $4,000
Q1 2022 May 12, 2022	BUY	$1.6 - $3.35 $3,704 - $7,755	2,315 Added 85.84%	5,012 $9,000
Q4 2021 Feb 10, 2022	BUY	$2.08 - $3.65 $5,609 - $9,844	2,697 New	2,697 $9,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $198M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.